WTA-10108-84122
4 vaccinations
3 coded responses
39 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
-
2020-12-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-18
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2020-12-22
- 2020-12-23
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Survey response — days 1–6 daily, dose 2MedDRA: Dyspepsia — Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe HeartburnMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2021-12-14
-
2021-12-17
Survey response — day 14, dose 3MedDRA: Gastroenteritis — Feeling: Fair · Be unable to work or attend schoolFree text: GastroenteritisMedDRA releases: 2024-11 · check-in free text available
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-03-04
- 2022-06-03
-
2022-09-19
Dose 4 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
-
2022-12-19
Survey response — 3 months, dose 4MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-19
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-20
-
2022-12-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-07 | priority 2/3 | |
| 2022-12-19 | Successful 2022-12-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Severe Heartburn
Release 10 — day 14, dose 3
Symptoms: Gastroenteritis
Release 12 — 3 months, dose 4
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Dyspepsia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release